HealthStream (HSTM)
Market Price (12/15/2025): $24.21 | Market Cap: $718.7 MilSector: Health Care | Industry: Health Care Technology
HealthStream (HSTM)
Market Price (12/15/2025): $24.21Market Cap: $718.7 MilSector: Health CareIndustry: Health Care Technology
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 21% | Weak multi-year price returns2Y Excs Rtn is -55%, 3Y Excs Rtn is -76% | |
| Low stock price volatilityVol 12M is 30% | ||
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 21% |
| Low stock price volatilityVol 12M is 30% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -55%, 3Y Excs Rtn is -76% |
Valuation, Metrics & Events
HSTM Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
HealthStream (HSTM) experienced a decline in its stock price, moving by -13.8% during the approximate time period from August 31, 2025, to December 15, 2025, due to several key factors: **1. Narrowed Full-Year 2025 Revenue Guidance:** Around October 2025, HealthStream narrowed its full-year 2025 revenue outlook, which can be seen by investors as a signal of potentially slower anticipated growth, even though the company reported stronger-than-expected third-quarter 2025 earnings. **2. Overall Negative One-Year Market Capitalization Trend:** Leading up to December 8, 2025, HealthStream's market capitalization had decreased by 25.05% over the preceding year, indicating a broader, sustained downward pressure on the stock that likely influenced its performance within the specified period. **3. Prevailing "Hold" Analyst Ratings:** Several analysts maintained a "Hold" rating for HSTM during this period, with some analysts specifically noting valuation concerns. A consensus of "Hold" ratings, rather than "Buy" recommendations, can limit investor interest and contribute to a stock's decline in the absence of strong upward catalysts. **4. Limited Upside Potential in Analyst Price Targets:** While some analyst reports indicated a "Moderate Buy" consensus, the average 12-month price targets often suggested limited upside from the stock's prevailing price, implying that analysts did not anticipate significant short-term growth, which could dampen investor confidence and contribute to a downward movement. **5. Market Perception of Declining Stock Despite Decent Financials:** Market analysis noted a sentiment regarding "Declining Stock and Decent Financials" for HealthStream, suggesting that despite reporting favorable financial results, the market might have harbored underlying concerns or applied a lower valuation to the company, leading to downward pressure on the stock price.
Show moreStock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| HSTM Return | -20% | 21% | -6% | 9% | 18% | -23% | -9% |
| Peers Return | 37% | 32% | -20% | 37% | 31% | -7% | 142% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 16% | 111% |
Monthly Win Rates [3] | |||||||
| HSTM Win Rate | 17% | 67% | 42% | 50% | 50% | 50% | |
| Peers Win Rate | 70% | 57% | 37% | 60% | 68% | 47% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| HSTM Max Drawdown | -33% | -1% | -28% | -17% | -11% | -24% | |
| Peers Max Drawdown | -29% | -9% | -34% | -6% | -8% | -22% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: WDAY, ORCL, NOW, ADP, PAYX.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/12/2025 (YTD)
How Low Can It Go
| Event | HSTM | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -38.0% | -25.4% |
| % Gain to Breakeven | 61.4% | 34.1% |
| Time to Breakeven | 875 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -34.5% | -33.9% |
| % Gain to Breakeven | 52.6% | 51.3% |
| Time to Breakeven | 240 days | 148 days |
| 2018 Correction | ||
| % Loss | -28.8% | -19.8% |
| % Gain to Breakeven | 40.4% | 24.7% |
| Time to Breakeven | 195 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -63.3% | -56.8% |
| % Gain to Breakeven | 172.4% | 131.3% |
| Time to Breakeven | 214 days | 1480 days |
Compare to OMCL, BEAT, CARL, HTFL, VEEV
In The Past
HealthStream's stock fell -38.0% during the 2022 Inflation Shock from a high on 8/16/2021. A -38.0% loss requires a 61.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
| Title | Topic | |
|---|---|---|
| DASHBOARDS | ||
| How Low Can HealthStream Stock Really Go? | Return | |
| HealthStream (HSTM) Operating Cash Flow Comparison | Financials | |
| HealthStream (HSTM) Net Income Comparison | Financials | |
| HealthStream (HSTM) Operating Income Comparison | Financials | |
| HealthStream (HSTM) Revenue Comparison | Financials |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select past ideas related to HSTM. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 15.0% | 15.0% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -5.1% | -5.1% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 9.0% | 9.0% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 2.3% | 2.3% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 16.0% | 16.0% | -5.1% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 15.0% | 15.0% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -5.1% | -5.1% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 9.0% | 9.0% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 2.3% | 2.3% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 16.0% | 16.0% | -5.1% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for HealthStream
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 207.23 |
| Mkt Cap | 85.9 |
| Rev LTM | 10,949 |
| Op Inc LTM | 1,981 |
| FCF LTM | 2,147 |
| FCF 3Y Avg | 2,123 |
| CFO LTM | 3,765 |
| CFO 3Y Avg | 3,166 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 9.1% |
| Rev Chg 3Y Avg | 8.6% |
| Rev Chg Q | 11.4% |
| QoQ Delta Rev Chg LTM | 2.7% |
| Op Mgn LTM | 20.0% |
| Op Mgn 3Y Avg | 18.5% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 32.1% |
| CFO/Rev 3Y Avg | 31.6% |
| FCF/Rev LTM | 24.1% |
| FCF/Rev 3Y Avg | 22.5% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 85.9 |
| P/S | 7.6 |
| P/EBIT | 28.8 |
| P/E | 46.4 |
| P/CFO | 24.5 |
| Total Yield | 2.7% |
| Dividend Yield | 0.6% |
| FCF Yield 3Y Avg | 3.6% |
| D/E | 0.0 |
| Net D/E | -0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 0.3% |
| 3M Rtn | -11.2% |
| 6M Rtn | -11.8% |
| 12M Rtn | -16.8% |
| 3Y Rtn | 21.1% |
| 1M Excs Rtn | 0.1% |
| 3M Excs Rtn | -13.4% |
| 6M Excs Rtn | -26.1% |
| 12M Excs Rtn | -29.9% |
| 3Y Excs Rtn | -50.3% |
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/3/2025 | 2.8% | -3.1% | -2.3% |
| 8/4/2025 | -1.2% | -0.3% | 7.8% |
| 5/5/2025 | -19.3% | -17.4% | -14.6% |
| 2/24/2025 | 0.1% | 3.4% | -1.0% |
| 10/21/2024 | 5.7% | 1.8% | 13.4% |
| 7/22/2024 | -4.0% | -4.2% | -7.7% |
| 2/20/2024 | -1.6% | -0.4% | -3.5% |
| 10/23/2023 | 14.9% | 14.1% | 16.3% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 8 | 6 |
| # Negative | 8 | 11 | 13 |
| Median Positive | 2.8% | 3.4% | 10.9% |
| Median Negative | -5.8% | -3.1% | -7.6% |
| Max Positive | 14.9% | 14.1% | 16.3% |
| Max Negative | -19.3% | -17.4% | -20.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11062025 | 10-Q 9/30/2025 |
| 6302025 | 8072025 | 10-Q 6/30/2025 |
| 3312025 | 5092025 | 10-Q 3/31/2025 |
| 12312024 | 2282025 | 10-K 12/31/2024 |
| 9302024 | 10242024 | 10-Q 9/30/2024 |
| 6302024 | 7252024 | 10-Q 6/30/2024 |
| 3312024 | 4252024 | 10-Q 3/31/2024 |
| 12312023 | 2262024 | 10-K 12/31/2023 |
| 9302023 | 10262023 | 10-Q 9/30/2023 |
| 6302023 | 7272023 | 10-Q 6/30/2023 |
| 3312023 | 4272023 | 10-Q 3/31/2023 |
| 12312022 | 2282023 | 10-K 12/31/2022 |
| 9302022 | 10272022 | 10-Q 9/30/2022 |
| 6302022 | 7282022 | 10-Q 6/30/2022 |
| 3312022 | 4282022 | 10-Q 3/31/2022 |
| 12312021 | 2282022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |